Biomea Fusion (BMEA) Amortizatization of Intangibles (2021 - 2023)
Biomea Fusion (BMEA) posted Amortizatization of Intangibles of -$1000.0 for Q1 2023, up 87.5% sequentially from -$8000.0 in Q4 2022, and up 99.0% YoY from -$502.51 in Q1 2022.
Biomea Fusion (BMEA) Amortizatization of Intangibles (2021 - 2023) Analysis & Trends
Biomea Fusion has reported Amortizatization of Intangibles for 3 years, with the latest figure at -$1000.0 in Q1 2023.
- Quarterly Amortizatization of Intangibles rose 99.0% year-over-year to -$1000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was -$1000.0 (up 99.31% YoY) and the FY2023 annual result came in at -$1000.0, up 99.31% from the prior year.
- Amortizatization of Intangibles rose to -$1000.0 in Q1 2023 per BMEA's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at -$1000.0 in Q1 2023 and troughed at -$157000.0 in Q3 2021.
- A 3-year average of -$65285.7 and a median of -$26000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles soared 93.63% in 2022, then surged 99.0% in 2023.
- Over 3 years, Amortizatization of Intangibles stood at -$155000.0 in 2021, then surged by 94.84% to -$8000.0 in 2022, then surged by 87.5% to -$1000.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$1000.0, -$8000.0, and -$10000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -8,000.00 |
| Dec 31, 2022 | -8,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Sep 30, 2022 | -10,000.00 |
| Jun 30, 2022 | -26,000.00 |
| Jun 30, 2022 | -26,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | -155,000.00 |
| Dec 31, 2021 | -155,000.00 |
| Sep 30, 2021 | -157,000.00 |
| Sep 30, 2021 | -157,000.00 |